Is Bird Flu Making a Comeback? Join us on Instagram Live on November 21st to find out what experts have to say about the recent emergence of a human H5N5 bird flu case in the U.S., and what it means for healthcare professionals.
After months of relative calm, the bird flu has made a surprising comeback. In the first human bird flu case in the U.S. since February, an older adult in Washington state was hospitalized with H5N5, a strain health officials said had not previously been identified in people. This case, along with 70 others reported in the U.S. since 2024, raises important questions for healthcare professionals.
But here's where it gets controversial... Some experts have criticized the decision to cancel $500 million in funding for mRNA vaccine development, calling it "reckless" in light of the bird flu threat.
In this Instagram Live, we'll hear from:
- Jeremy Faust, MD, editor-in-chief at MedPage Today, who will moderate the discussion.
- Angela Rasmussen, PhD, a virologist at the University of Saskatchewan, who will provide expert insights.
We'll explore:
- What this latest case of bird flu signals for the future.
- How clinicians can protect patients from bird flu.
- What to watch for next in the bird flu landscape.
Join us on Friday, November 21st at 11 a.m. ET to tune in and learn more!
And don't forget to submit your questions! We encourage you to share your thoughts and concerns in the comments below.
Related articles:
- Intranasal Vaccine Shows Promise Against Bird Flu in Early Trial
- Pulling the Plug on mRNA Vaccine Development Is 'Reckless,' Experts Say
- Washington Resident Is Infected With a Different Type of Bird Flu
Disclaimer: This Instagram Live is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for personalized medical advice.
